All

API

FDF

Price

Services

Excipients

Enquiries

Find

Active Pharmaceutical Ingredients
Finished Drug Formulations
Price
Excipients
Services
Marketplace

Market Place

Post Enquiry

Grow Your Pharma Business Digitally

Scorr-Insert

X

Find Clinical Drug Development Pipelines & Deals | PipelineProspector

A collaboration with SCORR Marketing

All Data

Filters

refresh

×

FILTER DATA :

News Type

Company

Product Type

Deal Size

Upfront Payment

refresh

Product Type

Companies

Alvotech

Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

ICELAND Iceland

Post An Enquiry

ASCO 2020

Participation Not Confirmed

Update your events

Alvotech and DKSH partner to bring key biosimilar to Asia

Contact the Supplier

Lead Product(s): Adalimumab

Therapeutic Area: Immunology

Highest Development Status: Phase III Product Type: Large molecule

Partner/Sponsor/Collaborator: DKSH Switzerland

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Partnership March 24, 2020

Details:

Under the partnership, Alvotech Hf will be responsible for the development and supply of AVT02, while DKSH will oversee its registration and commercialization.